Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Carbamazepine and oxcarbazepine decrease phenytoin metabolism through inhibition of CYP2C19.

F Lakehal1, C J Wurden, T F Kalhorn

  • 1Department of Pharmaceutics, University of Washington, Seattle, WA 98195-7610, USA.

Epilepsy Research
|November 30, 2002
PubMed
Summary

Carbamazepine (CBZ) and oxcarbazepine (OXC) metabolites inhibit CYP2C19, potentially increasing phenytoin levels. Caution is advised when co-administering these drugs with narrow therapeutic index medications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The amplitude and origin of sea-level variability during the Pliocene epoch.

Nature·2019
Same author

The multi-millennial Antarctic commitment to future sea-level rise.

Nature·2015
Same author

Antarctic contribution to meltwater pulse 1A from reduced Southern Ocean overturning.

Nature communications·2014
Same author

Evidence-based guideline: Antiepileptic drug selection for people with HIV/AIDS: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Ad Hoc Task Force of the Commission on Therapeutic Strategies of the International League Against Epilepsy.

Neurology·2012
Same author

Are circulating metabolites important in drug-drug interactions?: Quantitative analysis of risk prediction and inhibitory potency.

Clinical pharmacology and therapeutics·2010
Same author

Serum LH correlates highly with intratesticular steroid levels in normal men.

Journal of andrology·2009

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Medicinal Chemistry

Background:

  • Phenytoin levels can increase with carbamazepine (CBZ) co-medication.
  • Understanding the mechanism of drug-drug interactions is crucial for patient safety.

Purpose of the Study:

  • To investigate if carbamazepine (CBZ) and its metabolite (CBZE) inhibit CYP2C19-mediated phenytoin metabolism.
  • To evaluate the inhibitory effects of oxcarbazepine (OXC) and its metabolite (MHD) on CYP2C19.

Main Methods:

  • Utilized human liver microsomes to study drug metabolism.
  • Employed cDNA-expressed CYP2C19 to assess specific enzyme inhibition.
  • Measured the impact of CBZ, CBZE, OXC, and MHD on phenytoin metabolism.

Main Results:

Related Experiment Videos

  • Carbamazepine (CBZ) and its metabolite (MHD) demonstrated inhibition of CYP2C19-mediated phenytoin metabolism.
  • Inhibition occurred at therapeutic concentrations of CBZ and MHD.
  • CBZE did not significantly inhibit CYP2C19-mediated phenytoin metabolism.

Conclusions:

  • CBZ and OXC, through their metabolites, can inhibit CYP2C19.
  • Co-administration of CBZ or OXC with CYP2C19 substrates requires caution due to potential drug interactions.
  • This interaction may lead to altered therapeutic efficacy or toxicity of co-administered drugs.